We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ideagen Plc | LSE:IDEA | London | Ordinary Share | GB00B0CM0C50 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 349.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
07/11/2017 12:34 | I'm in, first buy of 3000 @ 86.6p | wanttowin | |
07/11/2017 11:19 | If I still had share certificates, this must be the most likely to be put away in the attic and have a look in 5 years... If it is one of those unusual businesses that just keeps growing, I wonder what a realistic market size for them is, in multiples of current revenue. Don't recall it mentioned but probably was somewhere. | yump | |
07/11/2017 11:15 | Ideagen Tipped in Motley Fool - :-) | smallcapwarrior | |
07/11/2017 09:42 | Yes sales probably capitalising short term gains. Strong cash position indicates well run company | turnerpa51 | |
07/11/2017 08:39 | Fincap retain their Buy and 108p target. Looks like a few traders are exiting - they probably made a penny or two over the last week I suppose: | rivaldo | |
07/11/2017 07:21 | Delighted with yet another strong set of results and forward outlook ! Well done David, Alan and the team :) | multibagger | |
07/11/2017 07:07 | Lovely trading statement today, particularly the optimism for the future and the increasing cash pile - another acquisition coming soon? "Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, today provides an update on trading for the six months ended 31 October 2017. The Board is pleased to report that trading has remained strong in the first half of the financial year and expects to report revenue and adjusted EBITDA* significantly ahead of the same period last year with an underlying organic revenue growth of approximately 12%. The Company continues to trade in line with market expectations for the full year to 30 April 2018. Cash generation in the period was strong and the Company maintains a robust balance sheet with no debt. The cash balance at the period end was £5.9 million (30 April 2017: £4.8 million). David Hornsby, Chief Executive Officer of Ideagen, commented: "I am pleased to report yet another strong start to Ideagen's financial year. Our core markets are strong and underpin the demand we have seen this half. Cash generation has been excellent and the Group has seen further growth in its recurring revenues and repeat business. The market opportunity remains large and long term and given the Group's position as a leader in the Governance, Risk and Compliance market, the Board is optimistic about the Group's continued growth prospects." | rivaldo | |
06/11/2017 12:11 | Contract win news today: "Major Academic Medical Center department to implement Q-Pulse for quality management within HIV vaccine manufacturing programme 06 November 2017 The Duke Human Vaccine Institute, a component of Duke Health, is to implement software from Ideagen to assist with quality management for an HIV vaccine manufacturing programme. Ideagen Q-Pulse will help staff catalogue and manage equipment maintenance and calibration records, training record logs, audits, deviations and corrective actions as part of its quality management system. Q-Pulse will also assist in the monitoring and management of vendors and change control and integrate risk assessments and risk mitigation through its risk and incident management functionality. etc" | rivaldo | |
06/11/2017 10:22 | Selftrade on Friday was only letting me buy a max of 500 shares. | jimbobaroony | |
06/11/2017 10:12 | Got my wife to buy some too, 4166 shares, shows on ADVFN as a sale !!! | turnerpa51 | |
06/11/2017 07:33 | Big kudos for IDEA: "Ideagen client nominated for international quality award thanks to Coruson project 02 November 2017 An Ideagen customer has been shortlisted for an industry leading quality award thanks to her work building a quality management and reporting system using Ideagen Coruson. Suzanne Burge, Quality and Assurance Manager at facilities management firm ISS, which manages the operations for Telefonica UK’s Property department, is a finalist at the International Quality Awards..... .....Ideagen Coruson, Ideagen’s enterprise cloud safety management software, was implemented by Suzanne and her Quality Assurance team (pictured above, left to right) of Lisa Wragg (Assurance Co-ordinator) and Sam Llewellyn (Management Information Manager). Coruson was chosen by ISS and Telefonica UK Property to manage governance, risk and compliance across its O2 estate. Suzanne added: “We wanted a product that that we could design ourselves to fit the needs of the business – not just now but in the future. A system that continues to add value to our operations and that’s what we got with Coruson. etc" | rivaldo | |
04/11/2017 10:17 | Well the markets seem to agree with you Gordon & you're probably spot on. The timing just seemed odd. All the best. | martinthebrave | |
03/11/2017 20:28 | Martin, You missed copying over the last paragraph. "Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that on 31 October 2017, Tri Castle Investments Ltd, a company wholly controlled by Jonathan Wearing, Non-Executive Chairman of the Company, sold 100,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at 79 pence per Ordinary Share (the "Transaction"). Following the Transaction, Jonathan Wearing will have a beneficial interest in 4,339,066 Ordinary Shares, representing approximately 2.17 % of the current issued share capital of the Company." --- I would respectfully suggest that v little can be read from a minor sale from such a large holding. To place in context, it only represented 2% of his entire holding & following the sale of £79k worth his remaining holding is currently valued at £3.8 million. Kind regards, GHF | glasshalfull | |
01/11/2017 17:27 | Very odd to see a 100k sale going through for Jonathan Wearing yesterday when the CEO has only recently mentioned "the half year for the company ends today, and shareholders should be very pleased with the results"? RNS: Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that on 31 October 2017, Tri Castle Investments Ltd, a company wholly controlled by Jonathan Wearing, Non-Executive Chairman of the Company, sold 100,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at 79 pence per Ordinary Share (the "Transaction"). Expecting an update within a week. | martinthebrave | |
01/11/2017 17:20 | Here is a blog post on the Ideagen AGM: | sharesoc | |
01/11/2017 11:57 | Yes a lovely reversal her after offering a great opportunity for a top up :-) | cheshire man | |
01/11/2017 10:11 | At last decent share price rise | turnerpa51 | |
01/11/2017 10:08 | Thanks to all for the updates. After holding these some years ago I recently bought again near the top, yes I never learn! But I felt, and still do, that the company is managed v well with sound products, what more can you ask for? - apart from rising divs and share price hopefully. | turnerpa51 | |
31/10/2017 17:54 | Thanks Roger. As I tweeted earlier today, I've been adding at recent levels. Like Martin I think the c.80p level offers decent support & as mentioned by both Martin & rivaldo, we may expect a trading update during the next fortnight. Roger's update indicates the CEO motioned that investors will be pleased with H1 results. I updated the header to this thread in October & reproduced finnCap's forecasts for 17/18 which have pencilled in Adj EPS of 4.2p which would translate into earnings growth of 32% this year. Not too shabby ;-) Kind regards, GHF | glasshalfull | |
31/10/2017 17:21 | Thank you Roger very interesting report. For what it is worth, this is the fourth time the share price has bounced off C:80p since June, so I think we safely say that we have a floor! In 2016 we had a 7th Nov update & as #IDEA are speaking at Sharesoc on the 8th I suspect this will be repeated next week. IMO (as a holder for some time), we should now get a rally leading up to the update followed by a test of the mid 90's high. | martinthebrave | |
31/10/2017 16:57 | I went to the Ideagen AGM yesterday - a brief report is here: hxxps://roliscon.blo | roger-lawson | |
30/10/2017 15:04 | Indeed - probably just a period of consolidation after a sharp rise into the spring. Given the strong outlook in the prelims only 3 months ago I remain positive - and there should be a trading update in the next week or two (7th November last year). | rivaldo | |
30/10/2017 14:10 | Riv, fundamentals look good as ever but don't like the way the chart is curling over. Could be in for a dull week or two. | superadams | |
30/10/2017 13:41 | More good news: "BDO UK extends the use of Ideagen’s Pentana Audit software 30 October 2017 Following its success in the UK, BDO South Africa’s Risk Advisory Services (RAS) division will be rolling out Pentana Audit BDO UK, part of the international accountancy and business advisory firm, is to extend its use of Ideagen’s internal auditing software to its South African member firm following its success in the United Kingdom. Pentana Audit will be rolled out across BDO South Africa’s Risk Advisory Service (RAS) offering to help with internal audit services for its clients. BDO South Africa’s RAS division provides outsourced internal audit services for organisations operating mainly within the mining sector. In addition to executing projects in South Africa, this division has a client base that reaches some neighbouring countries. etc" | rivaldo | |
18/10/2017 15:37 | Another contract. Inspiration Healthcare Group plc adopt Ideagen Q-Pulse for compliance & process management 18 October 2017 Inspiration Healthcare Group, a global supplier of medical technology for critical care, operating theatre and home healthcare applications, is adopting software from Ideagen to enhance regulatory compliance and key operational processes. Ideagen Q-Pulse, Ideagen’s flagship quality management software, will help the company maintain high levels of compliance to a number of regulatory bodies such as ISO 13485:2016, FDA 21 CFR part 820 and European Medical Device standards. Inspiration Healthcare manufactures and distributes its products to over 50 countries globally and will also adopt Q-Pulse for operational process management, particularly in relation to Design File History management – a key requirement for medical device manufacturers. Simon Travers, Head of Quality Assurance and Regulatory Affairs at Inspiration Healthcare, said: “For both compliance and operational reasons it was imperative that we brought Q-Pulse in. The software will make it easier for us to comply with several standards and satisfy the strict requirements of those notified bodies. “Although regulatory compliance was the main reason for adopting the software, there were many process reasons also. There will be document control and review, audit, corrective and preventive action benefits – not to mention Q-Pulse becoming a central repository for the management and review of suppliers, assets and staff competency management.” Inspiration Healthcare provides high-quality innovative products to patients and caregivers around the world that help to improve patient outcomes and efficiencies of healthcare organisations. Its products cover non-invasive respiratory management, thermoregulation, and patient warming for newborn babies through to adults in intensive care and the operating theatre. The company’s distribution business supplies solutions to support specialised surgical procedures and infusions therapies. A particular area of focus for the new Q-Pulse system will be in the management of the company’s Design File History documentation. Simon explained: “Within the medical device industry, organisations such as ours are required to maintain a Design History File – basically a complete story of how a product is created – for every product that is designed and taken to market. “We will be using the standard change request functionality within Q-Pulse to conduct periodic reviews every 12 months of our DFH documentation, ensuring we are on top of them. Q-Pulse will automatically remind stakeholders that a review is upcoming or overdue.” Ideagen, a UK-based software company which has a global footprint, provides software and services to more than 400 healthcare organisations globally, including 75% of the UK NHS. Other clients in this sector include Nuffield Health, Great Ormond Street Hospital, Spire Healthcare and El Camino Hospital. Ideagen’s software solutions – such as Ideagen Q-Pulse – help organisations manage quality, safety and compliance while improving patient care outcomes and clinical and operational efficiency. | igoe104 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions